BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28151721)

  • 21. Small GTPase Rab37 targets tissue inhibitor of metalloproteinase 1 for exocytosis and thus suppresses tumour metastasis.
    Tsai CH; Cheng HC; Wang YS; Lin P; Jen J; Kuo IY; Chang YH; Liao PC; Chen RH; Yuan WC; Hsu HS; Yang MH; Hsu MT; Wu CY; Wang YC
    Nat Commun; 2014 Sep; 5():4804. PubMed ID: 25183545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
    Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
    Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y
    Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma.
    Li L; Ma G; Jing C; Liu Z
    Discov Med; 2015 Dec; 20(112):369-78. PubMed ID: 26760981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
    Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
    Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
    Li Z; Jin H; Mao G; Wu L; Guo Q
    Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.
    Muramatsu T; Kozaki KI; Imoto S; Yamaguchi R; Tsuda H; Kawano T; Fujiwara N; Morishita M; Miyano S; Inazawa J
    Oncogene; 2016 Oct; 35(40):5304-5316. PubMed ID: 27041563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
    Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
    Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulation of SLIT2-mediated Cdc42 activity is associated with esophageal cancer metastasis and poor prognosis.
    Tseng RC; Chang JM; Chen JH; Huang WR; Tang YA; Kuo IY; Yan JJ; Lai WW; Wang YC
    J Thorac Oncol; 2015 Jan; 10(1):189-98. PubMed ID: 25490006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
    Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
    Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
    Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
    Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.